SBC Medical Group Holdings Incorporated
SBCWW
NASDAQ Global Market0.24
USD
+0.00
- -
SBC Medical Group Holdings Incorporated
SBCWW
(NASDAQ Global Market)
Recent
price
0.24
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) operates as a management services company that owns, operates, and franchises cosmetic treatment centers focused on aesthetic dermatology, plastic surgery, esthetic dentistry, and androgenetic alopecia treatments, primarily under the Shonan Beauty Clinic brand. The company provides comprehensive support to over 160 franchisee clinics in Japan, including advertising and marketing across social media platforms; staff recruitment, training, and management; customer booking reservations; employee housing and facility rentals; clinic construction and design; procurement and resale of medical equipment, devices, implants, injection materials, medical consumables, skin care products, beauty products, and cosmetics; program management; labor and operational support; management consulting; and IT software solutions. It also directly owns and operates treatment centers in Vietnam and the United States, with management services extended to locations in Singapore, serving a broad customer base of annual patients exceeding 3.9 million, of which 71% are repeat visitors. Founded in 2000 and headquartered in Irvine, California, SBC Medical Group Holdings maintains its primary operational focus in Japan alongside expanding international presence across Asia and North America. In July 2025, the company acquired MB Career Lounge Co., Ltd., a Japanese provider of consulting, training, and human resources services for medical institutions, integrating JUN Clinic—operated by Medical Corporation Misakikai—into its network to diversify offerings in aesthetic dermatology and plastic surgery, enhance revenue stability, and accelerate regional expansion through bank loan financing, with consolidation effective in Q3 2025. Earlier, in November 2024, SBC Medical entered the Thai market via a partnership with BLEZ and launched operations in Singapore through collaboration with Aesthetic Healthcare Holdings. In November 2025, the company commenced a tender offer for shares of Waqoo, Inc., signaling further strategic growth in the healthcare sector.